From GlobeNewswire: 2025-02-18 08:30:00

Myriad Genetics, Inc. (NASDAQ: MYGN) will hold its Q4 and full year 2024 earnings conference call on Feb. 24, 2025, at 4:30 pm ET. The company will release quarterly earnings the same day after the market closes, providing a financial overview and business update for the year.

A live webcast of the earnings call can be accessed on Myriad’s Investor Relations website. To participate via telephone, registration is required. Management will also participate in upcoming investor healthcare conferences to discuss the company’s performance and plans for the future.

Myriad Genetics is a genetic and genomic tumor testing company dedicated to advancing health and well-being. They offer genetic tests to assess disease risk and guide treatment decisions, aiming to improve patient care and lower healthcare costs. For more information, visit their website.



Read more at GlobeNewswire:: Myriad Genetics to Release Fourth Quarter and Full Year